Related Experiment Video
Updated: Feb 18, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Potassium Chloride Sustained Release Dosing Pathway in an Academic Medical Center
Bryan M Cook1, Danielle M Carter, Heather Dell'Orfano
1From the Department of Pharmacy, Brigham and Women's Hospital, Boston, MA.
Abstract:
Potassium supplementation can be administered intravenously or orally with either immediate release or sustained release formulations. Sustained release potassium chloride allows for delayed absorption and peak effects. In the inpatient setting, it is important to monitor and prevent both hypokalemia and hyperkalemia. Our tertiary-care academic hospital created a clinical pathway for sustained release potassium chloride supplementation in the inpatient population. Our clinical pathway for sustained release potassium chloride creates dosing restrictions designed to prevent hyperkalemia, while allowing exceptions for patients with high requirements.
Related Concept Videos
IV Infusion to Oral Dosing: Conversion Methods
Oral Drug Delivery Systems: Continuous-Release Systems
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Dosage Regimen: Multiple Oral Dosage
Modified-Release Drug Delivery Systems: Drug Release Characteristics

